Ortin Laboratories has informed that the 1% Extraordinary General Meeting for the financial year 2023-24 of Ortin Laboratories was held on Thursday, 14.12.2023 at 11:00 am through video conferencing/other audio-visual means. It has enclosed: Summary of proceedings as required under Regulation 30, Part-A of Schedule - III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations as Annexure - 1 and - Report of Scrutinizer pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014 as Annexure - II. The Meeting concluded at 11:15 AM. The Special Resolution as contained in the notice of 1st Extra Ordinary General Meeting of the Company for the financial year 2023-24 dated 14.11.2023 has been passed with the requisite majority (99.98% of the votes are cast in favour of the special resolution). Pursuant to Regulation 37A of SEBI (LODR) Regulations, 2015, the votes cast by the public shareholders in favour of the special resolution (99.95%) exceed the votes cast by public shareholders against the special resolution (0.05%).
The above information is a part of company’s filings submitted to BSE.